Osteotech
This article was originally published in The Gray Sheet
Executive Summary
Developer of Grafton demineralized bone matrix announces receipt of FDA 510(k) clearance Jan. 16 for the vertebral body replacement (VBR) system. Osteotech has exclusive distribution rights to the product in the U.S. and Canada. Manufactured by German firm Ulrich & Co., the device is indicated for use in the thoracolumbar apine (T1-L5) to replace a damaged vertebral body. Osteotech expects the product to target a $25 mil. niche of the spinal market